Inspiration Healthcare Group PLC Appointment of Dr. Peter Reynolds
23 Septiembre 2020 - 1:00AM
RNS Non-Regulatory
TIDMIHC
Inspiration Healthcare Group PLC
23 September 2020
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Appointment of Dr. Peter Reynolds
Inspiration Healthcare Group plc (AIM: IHC), the global medical
technology company, is pleased to announce that it has appointed
Dr. Peter Reynolds as the Group's Vice President for Clinical
Innovation and Compliance. Peter is a Consultant Neonatologist and
Paediatrician based at St. Peter's Hospital, Chertsey, Surrey and
has a strong track record in research, quality improvement and
teaching. He holds an MB.BS medical degree, a MSc (University of
London) in Clinical Paediatrics, and a PhD (Imperial College
London) in Immunology. He has also achieved the MRCPCH, MRCGP and
DRCOG Royal Colleges exams.
As a Consultant Neonatologist he specialises in the care of
premature and sick babies and the outpatient management of babies
and infants. Peter is also the clinical Speciality Neonatal Lead,
Neonatal Research Lead, Joint South East Neonatal Network Clinical
Lead, and Honorary Senior Lecturer at Royal Holloway University of
London. In 2018, he won the "Who Cares Wins" award for Best
Neonatal Specialist in the UK.
At Inspiration Healthcare, as a non-Board member he will work
closely with the senior management team to drive forward the
Company's clinical research, compliance (Quality Assurance and
Regulatory Affairs), R&D and Product management and will join
the Company on the 12(th) October 2020.
Dr. Reynolds said 'I am truly delighted to join this growing and
ambitious company which is focussed on developing important
products to help improve the outcomes of sick and premature babies.
I will bring my extensive clinical experience and knowledge of
neonatology to help lead clinical product development and future
innovations for the Group. This is an exciting challenge for me
personally and I look forward to making a real contribution to the
success of this dynamic company.'
Neil Campbell, Chief Executive Officer, commented, "We have
known Peter for many years and welcome his expertise and experience
which will be invaluable as the Company continues to grow and
upskill its clinical expertise . He is an extremely well known and
recognised figure in our specialist industry having written a wide
range of publications and through his teaching and lecturing in the
UK as well internationally and we are looking forward to working
with him."
Enquiries:
Inspiration Healthcare Group plc Tel: 01455 840555
Neil Campbell, Chief Executive Officer
Jon Ballard, Chief Financial Officer
Nominated Adviser & Broker Tel: 0207 397 8900
Cenkos Securities plc
Mark Connelly
Stephen Keys
Cameron MacRitchie
Cadogan PR Tel: 07771 713608
Alex Walters
alex.walters@cadoganpr.com
About Inspiration Healthcare Group
Inspiration Healthcare (AIM: IHC) is a global provider of
medical technology for use in neonatal intensive care &
operating theatres. The Company provides high quality innovative
products to patients around the world which help to improve patient
outcomes and it actively invests in innovative product
opportunities and disruptive technologies.
The Company has key own brand products that can be used within
the first days of life to help premature and sick babies; helping
resuscitation and stabilisation in the first moments of life
through to preventing brain damage and both invasive and
non-invasive respiratory support in terms of capital equipment and
disposable medical devices. Additionally, the Company has its own
range of products for maintaining normothermia pre, during and
post-surgery.
Since September 2019, the Company has acquired Vio Holdings a
designer, manufacturer and supplier of single use respiratory
products and sterile medical consumables and S.L.E., a leading
designer, manufacturer and global provider of neonatal ventilation
products . The Group generates approximately 60% of its revenues
from export markets and around two-thirds of its revenues come from
its own-branded products.
With product availability actively promoted to over 75 countries
through a distribution network, Inspiration Healthcare's success
has been built on continuous innovation, excellent customer service
and an inherent commitment to improving patient outcomes, working
in close collaboration with key opinion leaders across the
globe.
In the UK and Ireland the Group has direct sales teams selling
Group Branded and complementary products from third parties, with
an additional range of home healthcare products. This is supported
by Technical Support for planned preventative maintenance and
emergency assistance.
The Group operates from various sites in the UK for R&D,
Marketing and operations with manufacturing based in Croydon (south
London) and Hailsham (East Sussex). The Group's Head Office is
located in Crawley, a short distance from London's Gatwick Airport.
Further information on Inspiration Healthcare can be found at
www.inspiration-healthcare.com
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Private
Policy.
END
NRAKKBBQQBKDACB
(END) Dow Jones Newswires
September 23, 2020 02:00 ET (06:00 GMT)
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Inspiration Healthcare (LSE:IHC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024